2018
DOI: 10.1177/1538574418754453
|View full text |Cite
|
Sign up to set email alerts
|

Management and Outcome of Prosthetic Vascular Graft Infections: A Single Center Experience

Abstract: Prosthetic vascular graft infection needs a multidisciplinary management with appropriate antibiotherapy, radical removal of the infected graft, and in situ reconstruction. This strategy gives satisfactory results in terms of mortality, morbidity, patency rates, and infection control.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
20
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 25 publications
(20 citation statements)
references
References 28 publications
0
20
0
Order By: Relevance
“…The management of infected aneurysms remains a challenge in current practice, with reported hospital mortality rates ranging from 16 to 44%. [13] Almost all untreated aneurysm eventually leads to rupture. No randomized controlled trials exist to guide the treatment of infected aneurysms, with management strategies primarily based upon clinical experience and available case series.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The management of infected aneurysms remains a challenge in current practice, with reported hospital mortality rates ranging from 16 to 44%. [13] Almost all untreated aneurysm eventually leads to rupture. No randomized controlled trials exist to guide the treatment of infected aneurysms, with management strategies primarily based upon clinical experience and available case series.…”
Section: Discussionmentioning
confidence: 99%
“…A significant concern with in-situ reconstruction with prosthetic graft material is the development of prosthetic graft infection. Prosthetic graft infections occur in 1%–6% of cases after vascular graft implantation procedures [13]. Intraoperative bacterial contamination is cited as the most common cause, with other causes including bacterial colonization of the thrombus or direct inoculation.…”
Section: Discussionmentioning
confidence: 99%
“…Eleven studies reported on venous substitutes with an average score of 10.6. 9,18,21,22,25,26,29,32,33,35,36 Regarding the studies on arterial and prosthetic reconstructions, the average MI-NORS scores were 13.3 13,17,19,26e29,32,34,35 and 13.1. 5e 12,14e16,20,23,24,27e32 None of the studies met the criteria for good quality.…”
Section: Recurrence Of Infectionmentioning
confidence: 99%
“…23,32 Interestingly, these studies had the highest pooled recurrence rate of 39.3% (95% CI 13.2e 65.4), 23,32 while the average recurrence rate in 14 studies performing complete graft removal was 5.4% (95% CI 3.2e 7.5). 5,8,9,11,13,14,16,23,25,26,28,33,35,36 Analysis of the studies performing ISR demonstrated a pooled recurrent infection rate of 5.7% (95% CI 3.5e 8.0) 11,13,14,17,18,24e26,28,33,35 vs. a 4.1% (95% CI 3.3e12.8) recurrence rate for studies performing EAR. 16,23 Further analysis of the graft material used in those studies performing ISR demonstrated a pooled infection recurrence rate of 4.8% (95% CI 2.3e7.4; four studies) when autologous veins were used.…”
Section: Recurrence Of Infectionmentioning
confidence: 99%
“…Methicillin-resistant Staphylococcus epidermidis (MRSE) is the common cause of these infections, [9,10] which usually does not respond to antibiotherapy, requiring graft excision. [11] Mesenchymal stem cells (MSCs) have immunomodulatory and anti-inflammatory effect achieved by change in T helper subtypes, regulation of the activity of macrophages and changing proliferation, differentiation and immunsecretion characteristics of B cells. [12,13] They also show direct antibacterial effect achieved by secretion of antibacterial peptides and augmentation of phagocytosis.…”
mentioning
confidence: 99%